tiprankstipranks
Pfizer Inc (MX:PFE)
NYSE:PFE
Mexico Market
PFE
Pfizer
RESEARCH TOOLSreports

Pfizer (PFE) Ratios

0 Followers

Pfizer Ratios

MX:PFE's free cash flow for Q2 2026 was $0.73. For the 2026 fiscal year, MX:PFE's free cash flow was decreased by $ and operating cash flow was
lt;0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.27 1.16 1.17 0.91 1.22
Quick Ratio
 0.96 0.87 0.92 0.69 1.00
Cash Ratio
 0.03 0.03 0.02 0.06 <0.01
Solvency Ratio
 0.09 0.10 0.12 0.06 0.36
Operating Cash Flow Ratio
 0.41 0.32 0.30 0.18 0.69
Short-Term Operating Cash Flow Coverage
 4.97 3.36 1.83 0.84 9.98
Net Current Asset Value
$ -74.28B$ -78.49B$ -74.54B$ -93.88B$ -50.03B
Leverage Ratios
Debt-to-Assets Ratio
 0.31 0.32 0.31 0.31 0.18
Debt-to-Equity Ratio
 0.74 0.78 0.76 0.80 0.36
Debt-to-Capital Ratio
 0.43 0.44 0.43 0.44 0.27
Long-Term Debt-to-Capital Ratio
 0.42 0.42 0.39 0.40 0.25
Financial Leverage Ratio
 2.36 2.41 2.42 2.54 2.06
Debt Service Coverage Ratio
 2.37 2.50 1.81 0.85 9.04
Interest Coverage Ratio
 5.92 5.78 5.33 2.40 30.33
Debt to Market Cap
 0.40 0.46 0.43 0.44 0.12
Interest Debt Per Share
 11.56 12.33 12.37 12.95 6.44
Net Debt to EBITDA
 4.93 4.39 3.64 7.11 0.84
Profitability Margins
Gross Profit Margin
71.32%70.33%65.77%50.95%61.89%
EBIT Margin
10.84%16.29%17.47%5.49%35.85%
EBITDA Margin
19.82%24.12%28.49%16.05%40.90%
Operating Profit Margin
25.08%24.67%25.91%8.89%37.43%
Pretax Profit Margin
6.61%12.02%12.61%1.78%34.61%
Net Profit Margin
6.81%12.42%12.60%3.58%31.26%
Continuous Operations Profit Margin
6.87%12.44%12.65%3.65%31.30%
Net Income Per EBT
102.99%103.32%99.96%201.61%90.31%
EBT Per EBIT
26.35%48.71%48.67%19.99%92.49%
Return on Assets (ROA)
2.16%3.73%3.76%0.94%15.90%
Return on Equity (ROE)
4.89%8.99%9.09%2.40%32.79%
Return on Capital Employed (ROCE)
9.48%9.02%9.67%2.96%24.21%
Return on Invested Capital (ROIC)
9.33%8.84%9.28%2.80%21.49%
Return on Tangible Assets
5.24%9.34%8.97%2.27%30.61%
Earnings Yield
2.72%5.49%5.34%1.31%10.92%
Efficiency Ratios
Receivables Turnover
 5.10 3.95 4.31 3.83 6.91
Payables Turnover
 3.99 3.54 3.87 4.35 5.62
Inventory Turnover
 1.84 1.74 2.01 2.87 4.26
Fixed Asset Turnover
 3.35 2.91 3.46 3.14 6.17
Asset Turnover
 0.32 0.30 0.30 0.26 0.51
Working Capital Turnover Ratio
 7.41 9.43 43.85 25.56 7.68
Cash Conversion Cycle
 178.75 198.84 172.21 138.74 73.59
Days of Sales Outstanding
 71.57 92.39 84.77 95.27 52.86
Days of Inventory Outstanding
 198.71 209.46 181.84 127.31 85.72
Days of Payables Outstanding
 91.53 103.02 94.40 83.84 64.99
Operating Cycle
 270.29 301.86 266.61 222.57 138.58
Cash Flow Ratios
Operating Cash Flow Per Share
 2.35 2.06 2.25 1.54 5.22
Free Cash Flow Per Share
 1.93 1.60 1.74 0.85 4.64
CapEx Per Share
 0.42 0.46 0.51 0.69 0.58
Free Cash Flow to Operating Cash Flow
 0.82 0.78 0.77 0.55 0.89
Dividend Paid and CapEx Coverage Ratio
 1.10 0.94 1.03 0.66 2.40
Capital Expenditure Coverage Ratio
 5.55 4.45 4.38 2.23 9.04
Operating Cash Flow Coverage Ratio
 0.21 0.17 0.19 0.12 0.84
Operating Cash Flow to Sales Ratio
 0.21 0.19 0.20 0.15 0.29
Free Cash Flow Yield
6.88%6.41%6.55%2.95%9.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 37.01 18.31 18.68 76.17 9.16
Price-to-Sales (P/S) Ratio
 2.51 2.26 2.36 2.73 2.86
Price-to-Book (P/B) Ratio
 1.87 1.64 1.70 1.83 3.00
Price-to-Free Cash Flow (P/FCF) Ratio
 14.53 15.59 15.28 33.90 11.04
Price-to-Operating Cash Flow Ratio
 11.91 12.09 11.79 18.67 9.82
Price-to-Earnings Growth (PEG) Ratio
 -0.62 -4.33 0.07 -0.82 0.22
Price-to-Fair Value
 1.87 1.64 1.70 1.83 3.00
Enterprise Value Multiple
 17.57 13.76 11.93 24.11 7.84
Enterprise Value
 221.86B 207.77B 216.22B 230.45B 321.80B
EV to EBITDA
 17.57 13.76 11.93 24.11 7.84
EV to Sales
 3.48 3.32 3.40 3.87 3.21
EV to Free Cash Flow
 20.19 22.89 21.98 48.08 12.36
EV to Operating Cash Flow
 16.55 17.75 16.97 26.49 11.00
Tangible Book Value Per Share
 -5.79 -6.73 -6.26 -7.69 0.21
Shareholders’ Equity Per Share
 14.95 15.22 15.57 15.77 17.06
Tax and Other Ratios
Effective Tax Rate
 -0.04 -0.04 >-0.01 -1.05 0.10
Revenue Per Share
 11.18 11.01 11.23 10.55 17.89
Net Income Per Share
 0.76 1.37 1.42 0.38 5.59
Tax Burden
 1.03 1.03 1.00 2.02 0.90
Interest Burden
 0.61 0.74 0.72 0.32 0.97
Research & Development to Revenue
 0.20 0.19 0.17 0.18 0.11
SG&A to Revenue
 0.21 0.21 0.23 0.00 0.00
Stock-Based Compensation to Revenue
 0.01 0.00 0.01 <0.01 <0.01
Income Quality
 3.07 1.51 1.58 4.01 0.93
Currency in USD